Search results for "MYCOBACTERIUM TUBERCULOSIS"

showing 10 items of 159 documents

Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy

2008

Summary We report that a recently developed combined immunotherapy (CIT) has the capacity to prevent a spontaneous relapse of replicating Mycobacterium tuberculosis bacilli in the lungs of BALB/c, C57Bl/6 or C3H/HeJ strains of mice, following 4 weeks of non-sterilising treatment with isoniazid and rifampicin. The CIT regimen, represented by recombinant IFNγ, anti-α crystalline monoclonal IgA antibody and IL-4 neutralizing polyclonal antibody, reduced the 8-week relapse of viable bacterial counts in the lungs most significantly, when CIT was inoculated during the 5th week post infection, i.e. during the 3rd week of chemotherapy. Although CIT enhanced lung granuloma area, nitric oxide, cytoki…

MaleMicrobiology (medical)TuberculosisTuberculosiAntibodiemedicine.medical_treatmentImmunologyAntitubercular AgentsColony Count MicrobialMicrobiologyAntibodiesMycobacterium tuberculosisInterferon-gammaMiceAdjuvants ImmunologicRecurrencemedicineAnimalsalpha-CrystallinsRelapseTuberculosis PulmonaryCytokineMice Inbred BALB CMice Inbred C3HChemotherapyLungbiologybusiness.industryTuberculosis; Cytokines; Antibodies; Immunotherapy; RelapseIsoniazidMycobacterium tuberculosisImmunotherapybiology.organism_classificationmedicine.diseaseCombined Modality TherapyRecombinant ProteinsImmunoglobulin AMice Inbred C57BLRegimenInfectious Diseasesmedicine.anatomical_structureModels AnimalImmunologyInterleukin-4ImmunotherapybusinessRifampicinmedicine.drugTuberculosis
researchProduct

Phenotypical and functional analysis of memory and effector human CD8 T cells specific for mycobacterial antigens

2006

Abstract Mycobacterium tuberculosis infects one-third of the global population and claims two million lives every year. Because memory CD8 T cells exhibit a high heterogeneity in terms of phenotype and functional characteristic, we investigated the frequency, phenotype, and functional properties of Ag85A epitope-specific HLA-A*0201 CD8 T cells in children affected by tuberculosis (TB) before and 4 mo after chemotherapy and healthy contact children. Using Ag85A peptide/HLA-A*0201 pentamer, we found a low frequency of blood peptide-specific CD8 T cells in tuberculous children before therapy, which consistently increased after therapy to levels detected in healthy contacts. Ex vivo analysis of…

MalePore Forming Cytotoxic ProteinsLEPROSYImmunologyEpitopes T-LymphocyteCD8-Positive T-LymphocytesBiologyTuberculinTUBERCULOSISEpitopeImmunophenotypingInterferon-gammaInterleukin 21Immune systemImmunophenotypingAntigenT-Lymphocyte SubsetsHLA-A2 AntigenHumansBACILLE CALMETTE-GUERINImmunology and AllergyCytotoxic T cellLymphocyte CountChildTuberculosis PulmonaryAntigens BacterialMembrane GlycoproteinsIFN-GAMMACOMPLEXHLA-A AntigensPerforinHIGH-FREQUENCIESMycobacterium tuberculosisINTRACELLULAR INFECTIONNatural killer T cellVirologyBOVIS BCGMICEChild PreschoolTuberculosis MeningealImmunologyFemaleImmunologic MemoryCD8RESPONSES
researchProduct

gd T cells condition dendritic cells in vivo for priming pulmonary CD8 T cell responses against Mycobacterium tuberculosis

2006

gammadelta T cells and dendritic cells are quickly recruited to the lungs shortly after intranasal vaccination with BCG, but the functional in vivo interplay between these two cell populations and its role in the induction of adaptive immune responses is unclear. Using TCR-deficient mice and bone marrow chimeras, we show here that gammadelta T cells provide a non-redundant early source of IFN-gamma in vivo, which enhances IL-12 production by lung dendritic cells. The in vivo-conditioned dendritic cells, in turn, prime a more efficient lung CD8 T cell response against Mycobacterium tuberculosis. Thus, strategies exploiting gammadelta T cell function and IFN-gamma production could be valuable…

MaleT cellImmunologyBiologyCD8-Positive T-LymphocytesLymphocyte ActivationInterleukin 21Interferon-gammaMiceT-Lymphocyte SubsetsmedicineImmunology and AllergyCytotoxic T cellAnimalsTuberculosisIL-2 receptorAntigen-presenting cellLungFollicular dendritic cellsReceptors Antigen T-Cell gamma-deltaDendritic CellsMycobacterium tuberculosisNatural killer T cellFlow CytometryInterleukin-12Mice Mutant StrainsMice Inbred C57BLmedicine.anatomical_structureImmunologyInterleukin 12Female
researchProduct

Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines

2015

CD8 T cells contribute to protective immunity against Mycobacterium tuberculosis. In humans, M. tuberculosis reactive CD8 T cells typically recognize peptides associated to classical MHC class Ia molecules, but little information is available on CD8 T cells recognizing M. tuberculosis Ags presented by nonclassical MHC class Ib molecules. We show here that CD8 T cells from tuberculosis (TB) patients recognize HLA-E-binding M. tuberculosis peptides in a CD3/TCR αβ mediated and CD8-dependent manner, and represent an additional type of effector cells playing a role in immune response to M. tuberculosis during active infection. HLA-E-restricted recognition of M. tuberculosis peptides is detectab…

MaleTetramersCytotoxicHLA-EReceptors Antigen T-Cell alpha-betaT-LymphocytesEpitopes T-LymphocyteHIV InfectionsMycobacterium tuberculosiEpitopesHLA-EReceptorsImmunology and AllergyCells CulturedType 2 cytokinealpha-betaCulturedbiologyCoinfectionType 2 cytokinesMedicine (all)BacterialMiddle AgedAcquired immune systemAntibodies Bacterialmedicine.anatomical_structureTBAntigenCytokinesFemaleNK Cell Lectin-Like Receptor Subfamily CNK Cell Lectin-Like Receptor Subfamily DCD8 T lymphocyteProtein BindingAdultTuberculosisSettore MED/17 - Malattie InfettiveT cellCellsImmunologyAntibodiesMycobacterium tuberculosisImmune systemAntigenMHC class ImedicineHumansTuberculosisAntigensSettore MED/04 - Patologia GeneraleAntigens BacterialCD8 T lymphocytes; HLA-E; Mycobacterium tuberculosis; TB; Tetramers; Type 2 cytokines; Adult; Antibodies Bacterial; Antigens Bacterial; Cells Cultured; Coinfection; Cytokines; Epitopes T-Lymphocyte; Female; HIV Infections; Histocompatibility Antigens Class I; Humans; Male; Middle Aged; Mycobacterium tuberculosis; NK Cell Lectin-Like Receptor Subfamily C; NK Cell Lectin-Like Receptor Subfamily D; Protein Binding; Receptors Antigen T-Cell alpha-beta; T-Lymphocytes Cytotoxic; Tuberculosis; Immunology; Immunology and Allergy; Medicine (all)Histocompatibility Antigens Class IMycobacterium tuberculosismedicine.diseasebiology.organism_classificationT-CellVirologyCD8 T lymphocytesT-LymphocyteImmunologybiology.proteinTetramerT-Lymphocytes CytotoxicCD8 T lymphocytes; HLA-E; Mycobacterium tuberculosis; TB; Tetramers; Type 2 cytokines; Immunology; Immunology and Allergy
researchProduct

Tuberculosis of the central nervous system in children: 32 years survey.

2005

Aim. In order to study the impact of clinical and diagnostic parameters on the clinical outcome of children with central nervous system tuberculosis (CNS-TB), we retrospectively reviewed all cases of CNS-TB diagnosed over a 32-year period at the Children's Hospital of Palermo, Italy. Methods. Data were collected with regard to the clinical, laboratory and demographic characteristics of patients, as well as the results of radiological investigations and data on clinical outcome. In relation to the date of introduction of new diagnostic methods (indirect as well direct) and to the change of treatment periods, the authors compared the clinical outcome of patients admitted prior and after 1984.…

MaleTime FactorsTuberculosis Central Nervous System diagnosis drug therapyTuberculin TestData CollectionAge FactorsAntitubercular AgentsInfantMycobacterium tuberculosisTuberculosis Central Nervous SystemTreatment OutcomeItalyChild PreschoolData Interpretation StatisticalHumansFemaleChildRetrospective StudiesMinerva pediatrica
researchProduct

High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glyc…

2021

Upon infection withMycobacterium tuberculosis(Mtb) the host immune response might clear the bacteria, control its growth leading to latent tuberculosis (LTB), or fail to control its growth resulting in active TB (ATB). There is however no clear understanding of the features underlying a more or less effective response. Mtb glycolipids are abundant in the bacterial cell envelope and modulate the immune response to Mtb, but the patterns of response to glycolipids are still underexplored. To identify the CD45+leukocyte activation landscape induced by Mtb glycolipids in peripheral blood of ATB and LTB, we performed a detailed assessment of the immune response of PBMCs to the Mtb glycolipids lip…

Maleactive tuberculosis (ATB)T-LymphocytesPhosphatidylinositolsCohort Studies0302 clinical medicineImmunology and AllergyMyeloid CellsProspective StudiesOriginal ResearchAged 80 and overB-Lymphocytes0303 health sciencesLatent tuberculosishyporesponsivenessMiddle Aged3. Good healthphosphatidylinositol mannoside (PIM)Killer Cells NaturalCytokineslipids (amino acids peptides and proteins)Femalelatent tuberculosis (LTB)AdultImmunologymycobacterial glycolipidschemical and pharmacologic phenomenaIn Vitro TechniquesBiologyTuberculinPeripheral blood mononuclear cellMicrobiologyProinflammatory cytokineMycobacterium tuberculosisYoung Adult03 medical and health sciencesGlycolipidImmune systemLatent TuberculosismedicineHumansTuberculosisMass cytometryAged030304 developmental biologyAntigens BacterialLipoarabinomannanlipoarabinomannan (LAM)Mycobacterium tuberculosisRC581-607bacterial infections and mycosesmedicine.diseasebiology.organism_classificationToll-Like Receptor 2Case-Control StudiesImmunologic diseases. AllergyGlycolipids030215 immunologyFrontiers in Immunology
researchProduct

In vivo versus augmented reality exposure in the treatment of small animal phobia: A randomized controlled trial

2016

Although in vivo exposure is the treatment of choice for specific phobias, some acceptability problems have been associated with it. Virtual Reality exposure has been shown to be as effective as in vivo exposure, and it is widely accepted for the treatment of specific phobias, but only preliminary data are available in the literature about the efficacy of Augmented Reality. The purpose of the present study was to examine the efficacy and acceptance of two treatment conditions for specific phobias in which the exposure component was applied in different ways: In vivo exposure (N = 31) versus an Augmented Reality system (N = 32) in a randomized controlled trial. “One-session treatment” guidel…

Man-Computer InterfaceMale050103 clinical psychologyEmotionsSocial Scienceslcsh:MedicineCockroachesComputer Architecturelaw.inventionMathematical and Statistical Techniques0302 clinical medicineRandomized controlled triallawMedicine and Health SciencesPsychologyMedicineYoung adultSmall Animalslcsh:ScienceMultidisciplinary05 social sciencesVirtual RealitySpidersFearMiddle AgedpsychopathologyIntention to Treat AnalysisInsectsActinobacteriaspecific phobiasTreatment OutcomePhobic DisordersMeta-analysisPhysical SciencesEngineering and TechnologyFemaletreatment for SPStatistics (Mathematics)Research ArticlePsychopathologyClinical psychologyAdultsmall animal phobiaComputer and Information SciencesDrug Research and DevelopmentArthropodaPsychometricsAnimal TypesResearch and Analysis MethodsPhobic disorderVirtual Reality Exposure TherapyYoung Adult03 medical and health sciencesAnimalsHumansClinical Trials0501 psychology and cognitive sciencesStatistical MethodsAgedPharmacologyIntention-to-treat analysisBacteriabusiness.industryVirtual Reality Exposure Therapylcsh:ROrganismsBiology and Life SciencesInvertebratesRandomized Controlled Trials030227 psychiatryHuman Factors Engineeringlcsh:QAugmented realityClinical MedicinebusinessZoologyMycobacterium TuberculosisMathematicsUser InterfacesMeta-AnalysisFollow-Up Studies
researchProduct

Mutations in the rpoB and katG Genes Leading to Drug Resistance in Mycobacterium tuberculosis in Latvia

2002

ABSTRACT To characterize the genetic basis of drug resistance in Mycobacterium tuberculosis in Latvia, mutations involved in rifampin ( rpoB gene) and isoniazid ( katG gene) resistance in DNA from 19 drug-susceptible and 51 multidrug-resistant M. tuberculosis complex isolates were analyzed. The most frequent rpoB gene mutations found by the Line Probe assay were the S531L (14 of 34 isolates), D516V (7 of 34), H526D (4 of 34), and D516Y plus P535S (4 of 34) mutations. Direct sequencing of seven isolates with unclear results from Line Probe assay showed the presence of the L533P mutation and the Q510H plus H526Y (1 of 34) and D516V plus P535S (4 of 34) double mutations, neither of which has b…

Microbiology (medical)Antitubercular AgentsMicrobial Sensitivity TestsDrug resistanceGene mutationmedicine.disease_causeMycobacterium tuberculosischemistry.chemical_compoundBacterial ProteinsDrug Resistance BacterialmedicineHumansTuberculosisGenePlant ProteinsGeneticsMutationbiologyMycobacteriology and Aerobic ActinomycetesDNA-Directed RNA PolymerasesMycobacterium tuberculosisbiology.organism_classificationrpoBLatviaMolecular biologyDrug Resistance MultiplePeroxidaseschemistryMutationRestriction fragment length polymorphismDNAJournal of Clinical Microbiology
researchProduct

Role of hematopoietic cells in Mycobacterium tuberculosis infection.

2021

Tuberculosis remains one of the most significant causes of mortality worldwide and the current situation shows a re-emergence of TB due to the emergence of new antibiotic-resistant strains and the widespread of disease caused by immunodeficiencies. For these reasons, a big effort is made to improve the therapeutic strategies against Mycobacterium tuberculosis and to perform new therapeutic and diagnostic strategies. This review analyzes the various hematopoietic populations, their role and the different changes they undergo during Mycobacterium tuberculosis infection or disease. We have examined the population of lymphocytes, monocytes, neutrophils, eosinophils and platelets, in orderto und…

Microbiology (medical)Blood PlateletsMyeloidTuberculosisNeutrophilsImmunologyPopulationDiseaseMicrobiologyMonocytesMycobacterium tuberculosismedicineHumansTuberculosisLymphocytesProgenitor celleducationeducation.field_of_studyHematopoietic cellsbiologybusiness.industryMycobacterium tuberculosismedicine.diseasebiology.organism_classificationHematopoietic Stem CellsEosinophilsInfectious Diseasesmedicine.anatomical_structureImmunologyMyeloid cellsBone marrowStem cellbusinessLymphoid cellsTuberculosis (Edinburgh, Scotland)
researchProduct

Mycobacterium tuberculosis molecular evolution in western Mediterranean Island of Sicily and Sardinia

2004

Abstract In this study, a total of 204 Mycobacterium tuberculosis DNAs from Sicily ( n = 144) and Sardinia ( n = 60) were studied by three genotyping methods. Results were analyzed both within and across islands, to define the phylogeographical specificities of the genotypes, look for their diversity and infer a molecular evolutionary scenario. A strong link between geography and tuberculosis genotypes was observed in Sardinia. The results were also matched against a world-wide genetic diversity database to compare the population structure of the tubercle bacilli in the islands. Eight common genotypes between Sicily, Sardinia and continental Italy were found which underlines the influences …

Microbiology (medical)DNA BacterialGenotypeSardiniaMicrobiologyMycobacterium tuberculosisEvolution MolecularPhylogeneticsMolecular evolutionGeneticsHumansTuberculosisMolecular BiologyGenotypingSicilyEcology Evolution Behavior and SystematicsPhylogenyGenetic diversitybiologyHuman evolutionary geneticsGenetic VariationMycobacterium tuberculosisbiology.organism_classificationhumanitiesInfectious DiseasesMycobacterium tuberculosis complexItalyEvolutionary biologyMycobacterium tuberculosis complexMolecular evolutionMediterranean Islands
researchProduct